Flowcast
The landscape of the flow control industry, traditionally dominated by men, is changing. This shift is evident as we celebrate International Women’s Day, highlighting the significance of diversity and inclusion in sectors like engineered valves, pumps, and actuators. Studies show that companies with diverse leadership are 19% more likely to outperform their peers in…
Latest
Articles
A New Era in Pump Technology Innovation
Technological advancements are reshaping industries, and Trillium Flow Technologies stands at the forefront with its groundbreaking product launches for 2024. During a recent episode of FlowCast, Michelle Dawn Mooney delved deep into this innovation, revealing how Trillium’s integration of its Gabbioneta Pumps and Termomeccanica Pompe brands facilitated the development of new standards in pump…
Energy
Trillium Flow Technologies 2023 Year in Review: A Year of Innovation and Growth
Trillium Flow Technologies, 2023 year in review, looks back on a year marked with highlights that will usher in a fantastic 2024. As 2023 draws to a close, the industrial world reflects on a year marked by significant technological advancements and business growth. Trillium Flow Technologies, a leader in engineered valves, pumps, and actuators,…
Energy
The Hiller Grand Opening
The Hiller grand opening of its new facility and location marks exciting news for the nuclear power industry. As the energy demand continues to grow, the nuclear power industry is shifting from large base-load nuclear plants to smaller, more compact designs known as small modular reactors. With this shift comes the need for innovative…
Articles
FlowCast: Aftermarket Services Help Businesses Grow And Keep Customers Satisfied
In today’s rapidly evolving technological landscape, aftermarket services have become a pivotal aspect of customer satisfaction and business growth. As industries continue to innovate, the demand for efficient, reliable, and high-quality services has surged. A recent study indicates that these services are a significant revenue stream and a key differentiator in the market for businesses….
Energy
Trillium Flow Technologies Unveils Innovative Smart Flow Technology
In an era where Industry 4.0 is transforming the approach of manufacturing and maintenance, Trillium Flow Technologies keeps ahead of the trends with continual product enhancements and new product development, including investment in 3D technology. One of Trillium’s latest innovations is its smart flow technology, which provides a broad-based IIoT strategy through a combination…
Articles
Trillium’s Role in the Growing Hydrogen Market
Hydrogen is considered a greener and better alternative to other forms of gas energy production. It reduces emissions and can be produced from many sources, as opposed to only fossil fuels. The hydrogen market has a promising future but there are some key areas that need to be explored with its growth. Where is the…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
